Open main menu
ICRPaedia β

Oldest pages

Showing below up to 276 results in range #551 to #826.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Commissioning‏‎ (19:42, 11 August 2021)
  2. Compartment (environmental)‏‎ (19:44, 11 August 2021)
  3. Accreditation‏‎ (19:45, 11 August 2021)
  4. Backscatter detection system‏‎ (19:48, 11 August 2021)
  5. Clearance‏‎ (19:50, 11 August 2021)
  6. Concentration ratio‏‎ (19:52, 11 August 2021)
  7. Containment‏‎ (19:56, 11 August 2021)
  8. Cosmic radiation‏‎ (19:57, 11 August 2021)
  9. Derived reference level‏‎ (20:00, 11 August 2021)
  10. Derived limit‏‎ (20:00, 11 August 2021)
  11. Derived consideration reference level‏‎ (20:02, 11 August 2021)
  12. Designated area‏‎ (20:03, 11 August 2021)
  13. Evacuation‏‎ (20:07, 11 August 2021)
  14. Exclusion‏‎ (20:08, 11 August 2021)
  15. Exposed individuals‏‎ (20:09, 11 August 2021)
  16. Frequent flyer‏‎ (20:11, 11 August 2021)
  17. Ground-level enhancement‏‎ (20:12, 11 August 2021)
  18. ICRU 4-element tissue‏‎ (20:14, 11 August 2021)
  19. ICRU sphere‏‎ (20:17, 11 August 2021)
  20. Intervention‏‎ (20:18, 11 August 2021)
  21. Licensee‏‎ (20:20, 11 August 2021)
  22. National radon survey‏‎ (20:20, 11 August 2021)
  23. Nominal value‏‎ (20:21, 11 August 2021)
  24. Occupancy factor‏‎ (20:22, 11 August 2021)
  25. Operating management‏‎ (20:23, 11 August 2021)
  26. Potential exposure‏‎ (23:17, 11 August 2021)
  27. Collective dose‏‎ (23:18, 11 August 2021)
  28. Optimisation of protection‏‎ (23:22, 11 August 2021)
  29. Practice‏‎ (23:25, 11 August 2021)
  30. Principles of protection‏‎ (23:25, 11 August 2021)
  31. Radioactive waste‏‎ (23:29, 11 August 2021)
  32. Radiological attack‏‎ (23:30, 11 August 2021)
  33. Radon progeny‏‎ (23:30, 11 August 2021)
  34. Radon-prone area‏‎ (23:31, 11 August 2021)
  35. Redox‏‎ (23:31, 11 August 2021)
  36. Reference value‏‎ (23:34, 11 August 2021)
  37. Safety‏‎ (23:36, 11 August 2021)
  38. Region‏‎ (23:36, 11 August 2021)
  39. Sealed source‏‎ (23:38, 11 August 2021)
  40. Solar flare‏‎ (23:59, 11 August 2021)
  41. Sheltering‏‎ (00:00, 12 August 2021)
  42. Security‏‎ (00:01, 12 August 2021)
  43. Security screening‏‎ (00:02, 12 August 2021)
  44. Protection quantities‏‎ (14:51, 12 August 2021)
  45. Source-related assessment‏‎ (14:53, 12 August 2021)
  46. Superposition principle‏‎ (14:55, 12 August 2021)
  47. Surface contamination‏‎ (14:56, 12 August 2021)
  48. Thoron progeny‏‎ (14:57, 12 August 2021)
  49. Transmission detection system‏‎ (14:59, 12 August 2021)
  50. Trophic level‏‎ (15:00, 12 August 2021)
  51. Waste management‏‎ (15:05, 12 August 2021)
  52. Worker‏‎ (15:08, 12 August 2021)
  53. Working level‏‎ (15:14, 12 August 2021)
  54. Working level month‏‎ (15:17, 12 August 2021)
  55. Adenoma‏‎ (15:24, 12 August 2021)
  56. Air kerma at the patient entrance reference point‏‎ (15:27, 12 August 2021)
  57. Apoptosis‏‎ (15:29, 12 August 2021)
  58. AML/eto‏‎ (15:30, 12 August 2021)
  59. Automatic exposure control‏‎ (15:33, 12 August 2021)
  60. Brachytherapy‏‎ (15:34, 12 August 2021)
  61. Bragg peak‏‎ (15:37, 12 August 2021)
  62. Spread-out Bragg peak‏‎ (15:39, 12 August 2021)
  63. Breakpoint cluster region/abelson‏‎ (15:41, 12 August 2021)
  64. Broad beam therapy irradiation technique‏‎ (15:44, 12 August 2021)
  65. Carers and comforters‏‎ (15:48, 12 August 2021)
  66. Clinical audit‏‎ (15:50, 12 August 2021)
  67. Clonogenic surviving fraction‏‎ (15:52, 12 August 2021)
  68. Cobblestone area forming cell assay‏‎ (15:53, 12 August 2021)
  69. Collimation‏‎ (15:54, 12 August 2021)
  70. Cone beam computed tomography‏‎ (15:56, 12 August 2021)
  71. Dental and maxillofacial imaging‏‎ (16:01, 12 August 2021)
  72. Exposure index‏‎ (16:03, 12 August 2021)
  73. Detector quantum efficiency‏‎ (16:04, 12 August 2021)
  74. Diagnostic reference level‏‎ (16:09, 12 August 2021)
  75. Dose-length product‏‎ (16:11, 12 August 2021)
  76. DRL process‏‎ (16:14, 12 August 2021)
  77. DRL quantity‏‎ (16:18, 12 August 2021)
  78. Exogenous excretion‏‎ (16:19, 12 August 2021)
  79. Functional subunits‏‎ (16:24, 12 August 2021)
  80. Hounsfield unit‏‎ (16:43, 12 August 2021)
  81. Accelerated fractionation‏‎ (16:45, 12 August 2021)
  82. Hyperfractionation‏‎ (16:45, 12 August 2021)
  83. Intensity-modulated radiotherapy‏‎ (16:46, 12 August 2021)
  84. Local DRL‏‎ (16:49, 12 August 2021)
  85. National DRL‏‎ (16:50, 12 August 2021)
  86. DRL value‏‎ (16:51, 12 August 2021)
  87. Mean glandular dose‏‎ (17:28, 12 August 2021)
  88. Multi-detector computed tomography‏‎ (17:31, 12 August 2021)
  89. Multifactorial diseases‏‎ (17:31, 12 August 2021)
  90. Multitarget equation‏‎ (17:37, 12 August 2021)
  91. Noise‏‎ (17:38, 12 August 2021)
  92. Notification value‏‎ (17:41, 12 August 2021)
  93. Nuclear medicine‏‎ (17:42, 12 August 2021)
  94. Molecular imaging‏‎ (17:43, 12 August 2021)
  95. Organ at risk‏‎ (17:44, 12 August 2021)
  96. Oxygen enhancement ratio‏‎ (17:45, 12 August 2021)
  97. Pencil beam‏‎ (17:46, 12 August 2021)
  98. Pilomatricoma‏‎ (17:47, 12 August 2021)
  99. Potential recoverability correction factor‏‎ (17:49, 12 August 2021)
  100. Quality control testing‏‎ (17:51, 12 August 2021)
  101. Radiation-induced second cancer‏‎ (17:52, 12 August 2021)
  102. Radiation-induced secondary malignancy‏‎ (17:53, 12 August 2021)
  103. Ras‏‎ (17:55, 12 August 2021)
  104. Rb‏‎ (17:56, 12 August 2021)
  105. Referrer‏‎ (17:57, 12 August 2021)
  106. Reference air kerma‏‎ (17:59, 12 August 2021)
  107. Regional diagnostic reference levels‏‎ (18:01, 12 August 2021)
  108. Registry‏‎ (18:02, 12 August 2021)
  109. Relative survival‏‎ (18:03, 12 August 2021)
  110. Secondary radiation‏‎ (18:04, 12 August 2021)
  111. Shielding‏‎ (18:05, 12 August 2021)
  112. Size-specific dose estimate‏‎ (18:06, 12 August 2021)
  113. Slice‏‎ (18:07, 12 August 2021)
  114. Standard-size adult‏‎ (18:09, 12 August 2021)
  115. Stem cell‏‎ (18:10, 12 August 2021)
  116. Teratocarcinoma‏‎ (18:11, 12 August 2021)
  117. Time-resolved computed tomography‏‎ (18:13, 12 August 2021)
  118. Tolerance dose‏‎ (18:14, 12 August 2021)
  119. Digital breast tomosynthesis‏‎ (18:15, 12 August 2021)
  120. Treatment preparation in radiotherapy‏‎ (18:16, 12 August 2021)
  121. Typical value‏‎ (18:18, 12 August 2021)
  122. Absorbed fraction‏‎ (18:24, 12 August 2021)
  123. Source region‏‎ (18:27, 12 August 2021)
  124. Activity median aerodynamic diameter‏‎ (18:29, 12 August 2021)
  125. Ambient dose equivalent‏‎ (18:30, 12 August 2021)
  126. Annual intake‏‎ (18:31, 12 August 2021)
  127. Annual limit on intake‏‎ (18:37, 12 August 2021)
  128. Derived air concentration‏‎ (18:41, 12 August 2021)
  129. Biological half-life‏‎ (18:43, 12 August 2021)
  130. Bronchiolar region‏‎ (18:44, 12 August 2021)
  131. Charged-particle equilibrium‏‎ (18:45, 12 August 2021)
  132. Collective effective dose‏‎ (19:04, 12 August 2021)
  133. Compartment‏‎ (19:06, 12 August 2021)
  134. Cross section‏‎ (19:10, 12 August 2021)
  135. Cumulative dose‏‎ (19:11, 12 August 2021)
  136. Deposition‏‎ (19:13, 12 August 2021)
  137. Derived investigation level‏‎ (19:14, 12 August 2021)
  138. Directional dose equivalent‏‎ (19:16, 12 August 2021)
  139. Distribution coefficient‏‎ (19:18, 12 August 2021)
  140. Dose‏‎ (19:22, 12 August 2021)
  141. Absorbed dose‏‎ (19:22, 12 August 2021)
  142. Equivalent dose‏‎ (19:32, 12 August 2021)
  143. Dose commitment‏‎ (19:40, 12 August 2021)
  144. Dose conversion convention‏‎ (19:46, 12 August 2021)
  145. Dose conversion factor‏‎ (19:47, 12 August 2021)
  146. Dose of record (E)‏‎ (19:50, 12 August 2021)
  147. Dose of record Hp (10)‏‎ (19:52, 12 August 2021)
  148. Dose per content function‏‎ (18:26, 17 August 2021)
  149. DS86‏‎ (18:29, 17 August 2021)
  150. DS02‏‎ (18:29, 17 August 2021)
  151. Endosteum‏‎ (18:34, 17 August 2021)
  152. Equieffective dose‏‎ (18:41, 17 August 2021)
  153. Equilibrium equivalent concentration‏‎ (18:43, 17 August 2021)
  154. Equilibrium factor‏‎ (02:06, 18 August 2021)
  155. Excretion rate (instantaneous)‏‎ (02:08, 18 August 2021)
  156. Expanded and aligned radiation field‏‎ (02:11, 18 August 2021)
  157. Expanded radiation field‏‎ (02:12, 18 August 2021)
  158. Exposure (in the context of inhalation)‏‎ (02:14, 18 August 2021)
  159. Extrathoracic airways‏‎ (02:18, 18 August 2021)
  160. Human Respiratory Tract Model‏‎ (02:31, 18 August 2021)
  161. Human Alimentary Tract Model‏‎ (02:33, 18 August 2021)
  162. Gray‏‎ (02:34, 18 August 2021)
  163. Intake‏‎ (02:39, 18 August 2021)
  164. Kerma approximation‏‎ (16:58, 18 August 2021)
  165. Low linear energy transfer radiation‏‎ (17:19, 18 August 2021)
  166. High linear energy transfer radiation‏‎ (17:21, 18 August 2021)
  167. Linear energy transfer‏‎ (17:23, 18 August 2021)
  168. Marrow cellularity‏‎ (17:25, 18 August 2021)
  169. Count median diameter‏‎ (17:38, 18 August 2021)
  170. Mass median diameter‏‎ (17:39, 18 August 2021)
  171. Activity median thermodynamic diameter‏‎ (17:41, 18 August 2021)
  172. Thermodynamic diameter‏‎ (17:42, 18 August 2021)
  173. Measured quantity‏‎ (17:45, 18 August 2021)
  174. Organ/tissue absorbed dose‏‎ (18:14, 18 August 2021)
  175. OLINDA/EXM‏‎ (18:17, 18 August 2021)
  176. Other (systemic) tissues‏‎ (18:23, 18 August 2021)
  177. Particle transport‏‎ (18:24, 18 August 2021)
  178. Dose equivalent‏‎ (18:34, 18 August 2021)
  179. Organ dose equivalent‏‎ (18:36, 18 August 2021)
  180. Personal dose equivalent‏‎ (18:42, 18 August 2021)
  181. Operational quantity‏‎ (18:45, 18 August 2021)
  182. Phantom‏‎ (18:46, 18 August 2021)
  183. Potential alpha energy concentration‏‎ (18:48, 18 August 2021)
  184. Quality factor‏‎ (19:14, 18 August 2021)
  185. Radiation weighting factor‏‎ (19:25, 18 August 2021)
  186. Sievert‏‎ (19:36, 18 August 2021)
  187. Specific effective energy‏‎ (19:40, 18 August 2021)
  188. Dose coefficient‏‎ (18:10, 19 August 2021)
  189. Dose conversion coefficient‏‎ (18:10, 19 August 2021)
  190. Effective dose‏‎ (18:28, 19 August 2021)
  191. Reference individual‏‎ (18:34, 19 August 2021)
  192. Reference parameter value‏‎ (18:35, 19 August 2021)
  193. Reference Person‏‎ (18:39, 19 August 2021)
  194. Reference phantom‏‎ (18:45, 19 August 2021)
  195. Reference worker‏‎ (18:46, 19 August 2021)
  196. S coefficient (radiation weighted)‏‎ (18:57, 19 August 2021)
  197. Specific absorbed fraction‏‎ (19:01, 19 August 2021)
  198. Spongiosa‏‎ (19:04, 19 August 2021)
  199. Thoracic airways‏‎ (19:10, 19 August 2021)
  200. Investigation level‏‎ (19:11, 19 August 2021)
  201. Threshold level‏‎ (19:12, 19 August 2021)
  202. Non-maleficence‏‎ (19:38, 19 August 2021)
  203. Dignity‏‎ (19:51, 19 August 2021)
  204. Beneficence‏‎ (19:51, 19 August 2021)
  205. Prudence‏‎ (19:53, 19 August 2021)
  206. Equity‏‎ (19:55, 19 August 2021)
  207. ALARA‏‎ (20:02, 19 August 2021)
  208. Optimisation‏‎ (20:03, 19 August 2021)
  209. Alimentary tract‏‎ (20:14, 19 August 2021)
  210. Low Earth orbit‏‎ (01:58, 20 August 2021)
  211. Kerma‏‎ (14:12, 7 September 2021)
  212. Employer‏‎ (14:15, 7 September 2021)
  213. Justice‏‎ (14:18, 7 September 2021)
  214. Justification‏‎ (14:18, 7 September 2021)
  215. Kp index‏‎ (14:22, 7 September 2021)
  216. Fairness‏‎ (14:23, 7 September 2021)
  217. Field-size effect (Volume effect)‏‎ (14:23, 7 September 2021)
  218. Flexible tissues‏‎ (14:24, 7 September 2021)
  219. Fluoroscopically guided interventions‏‎ (14:24, 7 September 2021)
  220. Fluence‏‎ (14:24, 7 September 2021)
  221. Fluoroscopically or computed tomography guided interventions‏‎ (14:24, 7 September 2021)
  222. Forbiddenness‏‎ (14:25, 7 September 2021)
  223. Fractional absorption in the gastrointestinal tract‏‎ (14:25, 7 September 2021)
  224. Fractionation‏‎ (14:25, 7 September 2021)
  225. Fractionation and dose delivery patterns‏‎ (14:26, 7 September 2021)
  226. Fractionation sensitivity‏‎ (14:26, 7 September 2021)
  227. Galactic cosmic radiation‏‎ (14:27, 7 September 2021)
  228. Gamma ray‏‎ (14:27, 7 September 2021)
  229. Gastrointestinal syndrome‏‎ (14:27, 7 September 2021)
  230. Gastrulation‏‎ (14:27, 7 September 2021)
  231. Gastroschisis‏‎ (14:28, 7 September 2021)
  232. GATA binding protein 2‏‎ (14:28, 7 September 2021)
  233. Genomic integrity‏‎ (14:28, 7 September 2021)
  234. Rigidity threshold‏‎ (14:29, 7 September 2021)
  235. Graded approach‏‎ (14:29, 7 September 2021)
  236. Graft vs host disease‏‎ (14:29, 7 September 2021)
  237. Granulocyte colony-stimulating factor‏‎ (14:30, 7 September 2021)
  238. Granulocyte-macrophage colony-stimulating factor‏‎ (14:30, 7 September 2021)
  239. Growth factor‏‎ (14:31, 7 September 2021)
  240. Growth fraction‏‎ (14:31, 7 September 2021)
  241. Growth hormone (somatotropin)‏‎ (14:32, 7 September 2021)
  242. X ray‏‎ (14:33, 7 September 2021)
  243. Xerostomia‏‎ (14:33, 7 September 2021)
  244. Value judgement‏‎ (14:33, 7 September 2021)
  245. Valvular heart disease‏‎ (14:34, 7 September 2021)
  246. Virtue ethics‏‎ (14:34, 7 September 2021)
  247. Voxel phantom‏‎ (14:34, 7 September 2021)
  248. Unattached fraction‏‎ (14:55, 7 September 2021)
  249. Unsealed source‏‎ (14:56, 7 September 2021)
  250. Upper reference levels‏‎ (14:56, 7 September 2021)
  251. Uptake‏‎ (14:56, 7 September 2021)
  252. Utilitarian ethics‏‎ (14:57, 7 September 2021)
  253. Cohort study‏‎ (14:21, 3 October 2021)
  254. Lag‏‎ (14:24, 3 October 2021)
  255. Lifetime risk‏‎ (14:28, 3 October 2021)
  256. Absolute risk‏‎ (14:29, 3 October 2021)
  257. Risk‏‎ (14:29, 3 October 2021)
  258. Secretory cells‏‎ (14:31, 3 October 2021)
  259. ICRP Glossary‏‎ (14:37, 3 October 2021)
  260. ICRP Publication 140‏‎ (17:08, 3 October 2021)
  261. ICRP Publication 141‏‎ (17:10, 3 October 2021)
  262. ICRP Publication 142‏‎ (17:10, 3 October 2021)
  263. ICRP Publication 143‏‎ (17:11, 3 October 2021)
  264. ICRP Publication 144‏‎ (17:11, 3 October 2021)
  265. ICRP Publication 145‏‎ (17:12, 3 October 2021)
  266. ICRP Publication 146‏‎ (17:12, 3 October 2021)
  267. ICRP Publication 147‏‎ (17:13, 3 October 2021)
  268. ICRP Publication 148‏‎ (17:13, 3 October 2021)
  269. ICRP Publication 149‏‎ (17:13, 3 October 2021)
  270. ICRP Publication 150‏‎ (17:14, 3 October 2021)
  271. ICRP Publication 151‏‎ (17:14, 3 October 2021)
  272. ICRP Publication 152‏‎ (17:14, 3 October 2021)
  273. ICRP Publication 153‏‎ (17:15, 3 October 2021)
  274. ICRP Publication 154‏‎ (17:15, 3 October 2021)
  275. ICRP Publication 155‏‎ (17:15, 3 October 2021)
  276. ICRP publications‏‎ (17:57, 3 October 2021)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:AncientPages"